What is MapLight Therapeutics, Inc. Common Stock's Market Cap?

MapLight Therapeutics, Inc. Common Stock's Market Cap is $647.0M, based on as-reported figures from SEC (XBRL) filings.

What is MapLight Therapeutics, Inc. Common Stock's Enterprise Value?

MapLight Therapeutics, Inc. Common Stock's Enterprise Value is $342.2M, based on as-reported figures from SEC (XBRL) filings.

What is MapLight Therapeutics, Inc. Common Stock's EV / EBITDA?

MapLight Therapeutics, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.

What is MapLight Therapeutics, Inc. Common Stock's Net Income (TTM)?

MapLight Therapeutics, Inc. Common Stock's Net Income (TTM) is -$229.8M, based on as-reported figures from SEC (XBRL) filings.

What is MapLight Therapeutics, Inc. Common Stock's EBITDA?

MapLight Therapeutics, Inc. Common Stock's EBITDA is -$242.3M, based on as-reported figures from SEC (XBRL) filings.

What is MapLight Therapeutics, Inc. Common Stock's Diluted EPS (TTM)?

MapLight Therapeutics, Inc. Common Stock's Diluted EPS (TTM) is -4.96, based on as-reported figures from SEC (XBRL) filings.

What is MapLight Therapeutics, Inc. Common Stock's Net Debt?

MapLight Therapeutics, Inc. Common Stock's Net Debt is -$304.7M, based on as-reported figures from SEC (XBRL) filings.

MapLight Therapeutics, Inc. Common Stock (MPLT) Financial Statements

MapLight Therapeutics, Inc. Common Stock

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG01JZ5DBS8

XNAS · usd

13.95▲ 0.18 (1.31%)

As of 2026-09-08

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales—

EV / Revenue—

EV / EBITDA

Financial Highlights

Revenue (TTM)—

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin—

Net Debt

Trading Information

Previous Close13.77

Day's Range13.19 – 14.09

52-Week Range9.10 – 40.43

Volume521.8K

Avg Volume934.6K

Share Statistics

Shares Outstanding

Employees133

ExchangeXNAS

Listed2025-10-27

Share count as of August 7, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about MapLight Therapeutics, Inc. Common Stock (MPLT)

What is MapLight Therapeutics, Inc. Common Stock's Market Cap?: MapLight Therapeutics, Inc. Common Stock's Market Cap is $647.0M, based on as-reported figures from SEC (XBRL) filings.
What is MapLight Therapeutics, Inc. Common Stock's Enterprise Value?: MapLight Therapeutics, Inc. Common Stock's Enterprise Value is $342.2M, based on as-reported figures from SEC (XBRL) filings.
What is MapLight Therapeutics, Inc. Common Stock's EV / EBITDA?: MapLight Therapeutics, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is MapLight Therapeutics, Inc. Common Stock's Net Income (TTM)?: MapLight Therapeutics, Inc. Common Stock's Net Income (TTM) is -$229.8M, based on as-reported figures from SEC (XBRL) filings.
What is MapLight Therapeutics, Inc. Common Stock's EBITDA?: MapLight Therapeutics, Inc. Common Stock's EBITDA is -$242.3M, based on as-reported figures from SEC (XBRL) filings.
What is MapLight Therapeutics, Inc. Common Stock's Diluted EPS (TTM)?: MapLight Therapeutics, Inc. Common Stock's Diluted EPS (TTM) is -4.96, based on as-reported figures from SEC (XBRL) filings.
What is MapLight Therapeutics, Inc. Common Stock's Net Debt?: MapLight Therapeutics, Inc. Common Stock's Net Debt is -$304.7M, based on as-reported figures from SEC (XBRL) filings.